Results 71 to 80 of about 47,632 (221)

Visceral Leishmaniasis: Kala-azar [PDF]

open access: yesQJM, 2016
A 30-year-old male from rural northwest India presented to our hospital with fever of 4 weeks duration associated with abdominal pain. He was a farmer by occupation and gave history of sleeping in the open. General physical examination showed pallor and subcentimetric cervical lymphadenopathy.
R V, Nampoothiri   +3 more
openaire   +2 more sources

Advances in Microbial Diagnostics: Machine Learning and Nanotechnology for Zoonotic Disease Control

open access: yesWIREs Nanomedicine and Nanobiotechnology, Volume 18, Issue 1, January/February 2026.
This review highlights how integrating machine learning with nanotechnology enables enhanced diagnostics, personalized treatments, and the prediction of outbreaks for zoonotic diseases, offering a unified framework to advance global health. ABSTRACT Zoonotic diseases pose significant global health threats, with microbial pathogens, including bacteria ...
Narges Lotfalizadeh   +8 more
wiley   +1 more source

Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study

open access: yesBMC Research Notes, 2018
Objective Based on studies in India (as there was no studies from outside India) amphotericin B deoxycholate has been considered as a backup drug for treatment of visceral leishmaniasis.
Md Golam Hasnain   +7 more
doaj   +1 more source

Predicting the distribution of canine leishmaniasis in western Europe based on environmental variables. [PDF]

open access: yes, 2011
The domestic dog is the reservoir host of Leishmania infantum, the causative agent of zoonotic visceral leishmaniasis endemic in Mediterranean Europe. Targeted control requires predictive risk maps of canine leishmaniasis (CanL), which are now explored ...
ADRIAN MYLNE   +21 more
core   +2 more sources

Immunobiology of visceral leishmaniasis [PDF]

open access: yesFrontiers in Immunology, 2012
Visceral leishmaniasis (VL), commonly known as kala-azar, is caused by Leishmania donovani and Leishmania infantum (Leishmania chagasi in the Americas). These Leishmania species infect macrophages throughout the viscera, and parasites are typically found in the spleen, liver, and bone marrow.
Kumar, Rajiv, Nylén, Susanne
openaire   +3 more sources

Harnessing controlled human infection models to accelerate vaccine development for neglected tropical diseases: Lessons from leishmaniasis

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
Controlled Human Infection Models (CHIMs) offer a powerful approach to accelerate vaccine development for neglected tropical diseases (NTDs). This review highlights scientific and translational advances enabled by CHIMs, with a focus on a novel Leishmania major model.
Vivak Parkash
wiley   +1 more source

Visceral Leishmaniasis [PDF]

open access: yesMayo Clinic Proceedings, 2016
Giuseppe, Famularo, Stefano, Mancini
openaire   +3 more sources

Early suppression of lymphoproliferative response in dogs with natural infection by Leishmania infantum. [PDF]

open access: yes, 1999
Dogs are the domestic reservoirs of zoonotic visceral leishmaniasis caused by Leishmania infantum. Early detection of canine infections evolving to clinically patent disease may be important to leishmaniasis control.
CIARAMELLA, PAOLO   +8 more
core   +1 more source

Diagnosis of visceral leishmaniasis [PDF]

open access: yesTransactions of the Royal Society of Tropical Medicine and Hygiene, 2011
Leishmaniasis is a vector-borne disease with up to 350 million people at risk of infection worldwide. Among its different clinical manifestations, visceral is the most severe form. Since clinical features of visceral leishmaniasis (VL) mimic several other common diseases, accurate diagnosis is crucial as the treatment is associated with significant ...
Pankaj, Srivastava   +3 more
openaire   +2 more sources

Sex in Immune Cells and Parasitic Diseases — A Complex Relationship

open access: yesImmunological Reviews, Volume 337, Issue 1, January 2026.
ABSTRACT Epidemiological studies consistently show that many parasitic diseases affect males more frequently than females. These disparities are multifactorial, arising partly from gender‐specific behaviors that influence exposure risk and health‐seeking practices, especially in low‐ and middle‐income countries. Increasing evidence also highlights that
Barbara Honecker   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy